Cancer Research and Treatment

Original Articles

Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer: Ji Eun Oh, Min Ju Kim, Joohyung Lee, Bo Yun Hur, Bun Kim, Dae Yong Kim, Ji Yeon Baek, Hee Jin Chang, Sung Chan Park, Jae Hwan Oh, Sun Ah Cho, Dae Kyung Sohn; Cancer Res Treat. 2020;52(1):51-59. Published online May 7, 2019; DOI: https://doi.org/10.4143/crt.2019.050

Abstract PDF Supplementary Material PubReader ePub

Purpose
Mutation of the Kirsten Ras (KRAS) oncogene is present in 30%-40% of colorectal cancers and has prognostic significance in rectal cancer. In this study, we examined the ability of radiomics features extracted from T2-weighted magnetic resonance (MR) images to differentiate between tumors with mutant KRAS and wild-type KRAS.
Materials and Methods
Sixty patients with primary rectal cancer (25 with mutant KRAS, 35 with wild-type KRAS) were retrospectively enrolled. Texture analysis was performed in all regions of interest on MR images, which were manually segmented by two independent radiologists. We identified potentially useful imaging features using the two-tailed t test and used them to build a discriminant model with a decision tree to estimate whether KRAS mutation had occurred.
Results
Three radiomic features were significantly associated with KRASmutational status (p < 0.05). The mean (and standard deviation) skewness with gradient filter value was significantly higher in the mutant KRAS group than in the wild-type group (2.04±0.94 vs. 1.59±0.69). Higher standard deviations for medium texture (SSF3 and SSF4) were able to differentiate mutant KRAS (139.81±44.19 and 267.12±89.75, respectively) and wild-type KRAS (114.55±29.30 and 224.78±62.20). The final decision tree comprised three decision nodes and four terminal nodes, two of which designated KRAS mutation. The sensitivity, specificity, and accuracy of the decision tree was 84%, 80%, and 81.7%, respectively.
Conclusion
Using MR-based texture analysis, we identified three imaging features that could differentiate mutant from wild-type KRAS. T2-weighted images could be used to predict KRAS mutation status preoperatively in patients with rectal cancer.

Citations

Citations to this article as recorded by

CT-based radiomics integrated model for brain metastases in stage III/IV ALK-positive lung adenocarcinoma patients
Fen Wang, Caiyun Li, Shuke Li, Teng Zhang, Tongfu Yu, Wei Zhang, Jing He, Mei Yuan, Wen Gao
Frontiers in Oncology.2025;[Epub] CrossRef
Performance of Machine Learning in Diagnosing KRAS (Kirsten Rat Sarcoma) Mutations in Colorectal Cancer: Systematic Review and Meta-Analysis
Kaixin Chen, Yin Qu, Ye Han, Yan Li, Huiyan Gao, De Zheng
Journal of Medical Internet Research.2025; 27: e73528. CrossRef
Research progress on predicting KRAS gene mutations in colorectal cancer by combining radiomics and multimodal medical imaging
Min Ai, Li Li, Shimei Fan, Cheng He, Yi Guo, Yang He
Frontiers in Oncology.2025;[Epub] CrossRef
A segmentation-based hierarchical feature interaction attention model for gene mutation status identification in colorectal cancer
Yu Miao, Sijie Song, Lin Zhao, Jun Zhao, Yingsen Wang, Ran Gong, Yan Qiang, Hua Zhang, Juanjuan Zhao
Computerized Medical Imaging and Graphics.2025; 125: 102646. CrossRef
Differentiating small intestinal stromal tumors from primary small intestinal lymphomas using contrast-enhanced CT and texture analysis: a diagnostic study
Zhihua Li, Yiying Wang, Da Xi, Jian Wang, Haiyang Lan, Xiaoning He, Na Zhao, Juan Xiao, Naiwen Mu, Jianlong Li, Lincheng Liu, Guanghui Yu
Frontiers in Oncology.2025;[Epub] CrossRef
Impact of Radiomic and Artificial Intelligence on Colorectal Cancer: A Narrative Review
Caterina Battaglia, Maria Luisa Gambardella, Domenico Morano, Salvatore Cannavò, Ludovico Abenavoli, Domenico Laganà, Pier Paolo Arcuri
Applied Sciences.2025; 15(24): 13174. CrossRef
A multicenter study: predicting KRAS mutation and prognosis in colorectal cancer through a CT-based radiomics nomogram
Manman Li, Yiwen Yuan, Hui Zhou, Feng Feng, Guodong Xu
Abdominal Radiology.2024; 49(6): 1816. CrossRef
SG-Transunet: A segmentation-guided Transformer U-Net model for KRAS gene mutation status identification in colorectal cancer
Yulan Ma, Yuzhu Guo, Weigang Cui, Jingyu Liu, Yang Li, Yingsen Wang, Yan Qiang
Computers in Biology and Medicine.2024; 173: 108293. CrossRef
CHNet: A multi-task global–local Collaborative Hybrid Network for KRAS mutation status prediction in colorectal cancer
Meiling Cai, Lin Zhao, Yan Qiang, Long Wang, Juanjuan Zhao
Artificial Intelligence in Medicine.2024; 155: 102931. CrossRef
Assessment of prognostic indicators and KRAS mutations in rectal cancer using a fractional-order calculus MR diffusion model: whole tumor histogram analysis
Mi Zhou, Hongyun Huang, Deying Bao, Meining Chen, Fulin Lu
Abdominal Radiology.2024; 50(2): 569. CrossRef
The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer
Sebastian Curcean, Andra Curcean, Daniela Martin, Zsolt Fekete, Alexandru Irimie, Alina-Simona Muntean, Cosmin Caraiani
Cancers.2024; 16(17): 3111. CrossRef
A segmentation-based sequence residual attention model for KRAS gene mutation status prediction in colorectal cancer
Lin Zhao, Kai Song, Yulan Ma, Meiling Cai, Yan Qiang, Jingyu Sun, Juanjuan Zhao
Applied Intelligence.2023; 53(9): 10232. CrossRef
Rectal MRI Interpretation After Neoadjuvant Therapy
Natally Horvat, Maria El Homsi, Joao Miranda, Yousef Mazaheri, Marc J. Gollub, Viktoriya Paroder
Journal of Magnetic Resonance Imaging.2023; 57(2): 353. CrossRef
Association between Dynamic Contrast-Enhanced MRI Parameters and Prognostic Factors in Patients with Primary Rectal Cancer
Hye Ri Kim, Seung Ho Kim, Kyung Han Nam
Current Oncology.2023; 30(2): 2543. CrossRef
Virtual biopsy in abdominal pathology: where do we stand?
Arianna Defeudis, Jovana Panic, Giulia Nicoletti, Simone Mazzetti, Valentina Giannini, Daniele Regge
BJR|Open.2023;[Epub] CrossRef
Repeatability of radiomics studies in colorectal cancer: a systematic review
Ying Liu, Xiaoqin Wei, Xu Feng, Yan Liu, Guiling Feng, Yong Du
BMC Gastroenterology.2023;[Epub] CrossRef
The Role of Radiomics in Rectal Cancer
Joao Miranda, Natally Horvat, Jose A. B. Araujo-Filho, Kamila S. Albuquerque, Charlotte Charbel, Bruno M. C. Trindade, Daniel L. Cardoso, Lucas de Padua Gomes de Farias, Jayasree Chakraborty, Cesar Higa Nomura
Journal of Gastrointestinal Cancer.2023; 54(4): 1158. CrossRef
Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions
Niall J. O’Sullivan, Michael E. Kelly
Current Oncology.2023; 30(5): 4936. CrossRef
Construction of prediction model for KRAS mutation status of colorectal cancer based on CT radiomics
Yuntai Cao, Jing Zhang, Lele Huang, Zhiyong Zhao, Guojin Zhang, Jialiang Ren, Hailong Li, Hongqian Zhang, Bin Guo, Zhan Wang, Yue Xing, Junlin Zhou
Japanese Journal of Radiology.2023; 41(11): 1236. CrossRef
Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review
Giuseppe Di Costanzo, Raffaele Ascione, Andrea Ponsiglione, Anna Giacoma Tucci, Serena Dell’Aversana, Francesca Iasiello, Enrico Cavaglià
Exploration of Targeted Anti-tumor Therapy.2023; : 406. CrossRef
Investigating the Feasibility of Predicting KRAS Status, Tumor Staging, and Extramural Venous Invasion in Colorectal Cancer Using Inter-Platform Magnetic Resonance Imaging Radiomic Features
Mohammed S. Alshuhri, Abdulaziz Alduhyyim, Haitham Al-Mubarak, Ahmad A. Alhulail, Othman I. Alomair, Yahia Madkhali, Rakan A. Alghuraybi, Abdullah M. Alotaibi, Abdullalh G. M. Alqahtani
Diagnostics.2023; 13(23): 3541. CrossRef
Radiogenomics: Contemporary Applications in the Management of Rectal Cancer
Niall J. O’Sullivan, Hugo C. Temperley, Michelle T. Horan, Alison Corr, Brian J. Mehigan, John O. Larkin, Paul H. McCormick, Dara O. Kavanagh, James F. M. Meaney, Michael E. Kelly
Cancers.2023; 15(24): 5816. CrossRef
KRAS status predicted by pretreatment MRI radiomics was associated with lung metastasis in locally advanced rectal cancer patients
Yirong Xiang, Shuai Li, Maxiaowei Song, Hongzhi Wang, Ke Hu, Fengwei Wang, Zhi Wang, Zhiyong Niu, Jin Liu, Yong Cai, Yongheng Li, Xianggao Zhu, Jianhao Geng, Yangzi Zhang, Huajing Teng, Weihu Wang
BMC Medical Imaging.2023;[Epub] CrossRef
Segmentation-based multi-scale attention model for KRAS mutation prediction in rectal cancer
Kai Song, Zijuan Zhao, Jiawen Wang, Yan Qiang, Juanjuan Zhao, Muhammad Bilal Zia
International Journal of Machine Learning and Cybernetics.2022; 13(5): 1283. CrossRef
A multitask dual‐stream attention network for the identification of KRAS mutation in colorectal cancer
Kai Song, Zijuan Zhao, Yulan Ma, JiaWen Wang, Wei Wu, Yan Qiang, Juanjuan Zhao, Suman Chaudhary
Medical Physics.2022; 49(1): 254. CrossRef
Multi-Omic Approaches in Colorectal Cancer beyond Genomic Data
Emilia Sardo, Stefania Napolitano, Carminia Maria Della Corte, Davide Ciardiello, Antonio Raucci, Gianluca Arrichiello, Teresa Troiani, Fortunato Ciardiello, Erika Martinelli, Giulia Martini
Journal of Personalized Medicine.2022; 12(2): 128. CrossRef
The application of radiomics in predicting gene mutations in cancer
Yana Qi, Tingting Zhao, Mingyong Han
European Radiology.2022; 32(6): 4014. CrossRef
The prognostic effect of PNN in digestive tract cancers and its correlation with the tumor immune landscape in colon adenocarcinoma
Hui Zhang, Ming Jin, Meng Ye, Yanping Bei, Shaohui Yang, Kaitai Liu
Journal of Clinical Laboratory Analysis.2022;[Epub] CrossRef
18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
Giulia Capelli, Cristina Campi, Quoc Riccardo Bao, Francesco Morra, Carmelo Lacognata, Pietro Zucchetta, Diego Cecchin, Salvatore Pucciarelli, Gaya Spolverato, Filippo Crimì
Nuclear Medicine Communications.2022; 43(7): 815. CrossRef
Radiomics model based on multi-sequence MR images for predicting preoperative immunoscore in rectal cancer
Kaiming Xue, Lin Liu, Yunxia Liu, Yan Guo, Yuhang Zhu, Mengchao Zhang
La radiologia medica.2022; 127(7): 702. CrossRef
Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells
Sukanya Unson, Tung-Cheng Chang, Yung-Ning Yang, Shwu-Huey Wang, Chi-Hung Huang, Dana R. Crawford, Haw-Ming Huang, Zi-Lin Li, Hung-Yun Lin, Jacqueline Whang-Peng, Kuan Wang, Paul J. Davis, Wen-Shan Li
Marine Drugs.2022; 20(8): 482. CrossRef
Association between Texture Analysis Parameters and Molecular Biologic KRAS Mutation in Non-Mucinous Rectal Cancer
Sung Jae Jo, Seung Ho Kim, Sang Joon Park, Yedaun Lee, Jung Hee Son
Journal of the Korean Society of Radiology.2021; 82(2): 406. CrossRef
Actualización de la recomendación para la determinación de biomarcadores en el carcinoma colorrectal. Consenso Nacional de la Sociedad Española de Oncología Médica y de la Sociedad Española de Anatomía Patológica
Samuel Navarro, Miriam Cuatrecasas, Javier Hernández-Losa, Stefania Landolfi, Eva Musulén, Santiago Ramón y Cajal, Rocío García-Carbonero, Jesús García-Foncillas, Pedro Pérez-Segura, Ramón Salazar, Ruth Vera, Pilar García-Alfonso
Revista Española de Patología.2021; 54(1): 41. CrossRef
Texture analysis using T1-weighted images for muscles in Charcot-Marie-Tooth disease patients and volunteers
Ji Hyun Lee, Young Cheol Yoon, Hyun Su Kim, Jae-Hun Kim, Byung-Ok Choi
European Radiology.2021; 31(5): 3508. CrossRef
Radiomics signature of brain metastasis: prediction of EGFR mutation status
Guangyu Wang, Bomin Wang, Zhou Wang, Wenchao Li, Jianjun Xiu, Zhi Liu, Mingyong Han
European Radiology.2021; 31(7): 4538. CrossRef
Radiomics and Magnetic Resonance Imaging of Rectal Cancer: From Engineering to Clinical Practice
Francesca Coppola, Valentina Giannini, Michela Gabelloni, Jovana Panic, Arianna Defeudis, Silvia Lo Monaco, Arrigo Cattabriga, Maria Adriana Cocozza, Luigi Vincenzo Pastore, Michela Polici, Damiano Caruso, Andrea Laghi, Daniele Regge, Emanuele Neri, Rita
Diagnostics.2021; 11(5): 756. CrossRef
MRI Radiomics Signature as a Potential Biomarker for Predicting KRAS Status in Locally Advanced Rectal Cancer Patients
ZhiYuan Zhang, LiJun Shen, Yan Wang, Jiazhou Wang, Hui Zhang, Fan Xia, JueFeng Wan, Zhen Zhang
Frontiers in Oncology.2021;[Epub] CrossRef
Differentiating TP53 Mutation Status in Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI-Derived Radiomics
Jing Gao, Xiahan Chen, Xudong Li, Fei Miao, Weihuan Fang, Biao Li, Xiaohua Qian, Xiaozhu Lin
Frontiers in Oncology.2021;[Epub] CrossRef
Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
Zhuokai Zhuang, Zongchao Liu, Juan Li, Xiaolin Wang, Peiyi Xie, Fei Xiong, Jiancong Hu, Xiaochun Meng, Meijin Huang, Yanhong Deng, Ping Lan, Huichuan Yu, Yanxin Luo
Journal of Translational Medicine.2021;[Epub] CrossRef
Systematic Review on the Association of Radiomics with Tumor Biological Endpoints
Agustina La Greca Saint-Esteven, Diem Vuong, Fabienne Tschanz, Janita E. van Timmeren, Riccardo Dal Bello, Verena Waller, Martin Pruschy, Matthias Guckenberger, Stephanie Tanadini-Lang
Cancers.2021; 13(12): 3015. CrossRef
Emerging applications of radiomics in rectal cancer: State of the art and future perspectives
Min Hou, Ji-Hong Sun
World Journal of Gastroenterology.2021; 27(25): 3802. CrossRef
Spatial-Frequency dual-branch attention model for determining KRAS mutation status in colorectal cancer with T2-weighted MRI
Yulan Ma, Jiawen Wang, Kai Song, Yan Qiang, Xiong Jiao, Juanjuan Zhao
Computer Methods and Programs in Biomedicine.2021; 209: 106311. CrossRef
Textural differences based on apparent diffusion coefficient maps for discriminating pT3 subclasses of rectal adenocarcinoma
Zhi-Hua Lu, Kai-Jian Xia, Heng Jiang, Jian-Long Jiang, Mei Wu
World Journal of Clinical Cases.2021; 9(24): 6987. CrossRef
2. Radiomics of MRI
Koji Sakai
Japanese Journal of Radiological Technology.2021; 77(8): 866. CrossRef
Radiomics and machine learning applications in rectal cancer: Current update and future perspectives
Arnaldo Stanzione, Francesco Verde, Valeria Romeo, Francesca Boccadifuoco, Pier Paolo Mainenti, Simone Maurea
World Journal of Gastroenterology.2021; 27(32): 5306. CrossRef
Role of MRI‑based radiomics in locally advanced rectal cancer (Review)
Siyu Zhang, Mingrong Yu, Dan Chen, Peidong Li, Bin Tang, Jie Li
Oncology Reports.2021;[Epub] CrossRef
Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer
Yanfen Cui, Huanhuan Liu, Jialiang Ren, Xiaosong Du, Lei Xin, Dandan Li, Xiaotang Yang, Dengbin Wang
European Radiology.2020; 30(4): 1948. CrossRef
Multi-branch cross attention model for prediction of KRAS mutation in rectal cancer with t2-weighted MRI
JiaWen Wang, YanFen Cui, GuoHua Shi, JuanJuan Zhao, XiaoTang Yang, Yan Qiang, QianQian Du, Yue Ma, Ntikurako Guy-Fernand Kazihise
Applied Intelligence.2020; 50(8): 2352. CrossRef
Development and validation of a radiomics model based on T2WI images for preoperative prediction of microsatellite instability status in rectal cancer
Zixing Huang, Wei Zhang, Du He, Xing Cui, Song Tian, Hongkun Yin, Bin Song
Medicine.2020; 99(10): e19428. CrossRef
PET/MRI Radiomics in Rectal Cancer: a Pilot Study on the Correlation Between PET- and MRI-Derived Image Features with a Clinical Interpretation
Barbara Juarez Amorim, Angel Torrado-Carvajal, Shadi A Esfahani, Sara S Marcos, Mark Vangel, Dan Stein, David Groshar, Onofrio A Catalano
Molecular Imaging and Biology.2020; 22(5): 1438. CrossRef
MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC)
Filippo Crimì, Giulia Capelli, Gaya Spolverato, Quoc Riccardo Bao, Anna Florio, Sebastiano Milite Rossi, Diego Cecchin, Laura Albertoni, Cristina Campi, Salvatore Pucciarelli, Roberto Stramare
La radiologia medica.2020; 125(12): 1216. CrossRef
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology
P. García-Alfonso, R. García-Carbonero, J. García-Foncillas, P. Pérez-Segura, R. Salazar, R. Vera, S. Ramón y Cajal, J. Hernández-Losa, S. Landolfi, E. Musulén, M. Cuatrecasas, S. Navarro
Clinical and Translational Oncology.2020; 22(11): 1976. CrossRef
MRI-Based Texture Features as Potential Prognostic Biomarkers in Anaplastic Astrocytoma Patients Undergoing Surgical Treatment
Yang Zhang, Chaoyue Chen, Yangfan Cheng, Danni Cheng, Fumin Zhao, Jianguo Xu
Contrast Media & Molecular Imaging.2020; 2020: 1. CrossRef
Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning
Yu Li, Aydin Eresen, Junjie Shangguan, Jia Yang, Al B. Benson, Vahid Yaghmai, Zhuoli Zhang
Journal of Cancer Research and Clinical Oncology.2020; 146(12): 3165. CrossRef
Diffusion-Weighted MRI and Diffusion Kurtosis Imaging to Detect RAS Mutation in Colorectal Liver Metastasis
Vincenza Granata, Roberta Fusco, Chiara Risi, Alessandro Ottaiano, Antonio Avallone, Alfonso De Stefano, Robert Grimm, Roberta Grassi, Luca Brunese, Francesco Izzo, Antonella Petrillo
Cancers.2020; 12(9): 2420. CrossRef
CT Radiomics in Colorectal Cancer: Detection of KRAS Mutation Using Texture Analysis and Machine Learning
Víctor González-Castro, Eva Cernadas, Emilio Huelga, Manuel Fernández-Delgado, Jacobo Porto, José Ramón Antunez, Miguel Souto-Bayarri
Applied Sciences.2020; 10(18): 6214. CrossRef
Cancer Genotypes Prediction and Associations Analysis From Imaging Phenotypes: A Survey on Radiogenomics
Yao Wang, Yan Wang, Chunjie Guo, Xuping Xie, Sen Liang, Ruochi Zhang, Wei Pang, Lan Huang
Biomarkers in Medicine.2020; 14(12): 1151. CrossRef
Diagnostic performance of multiparametric MRI parameters for Gleason score and cellularity metrics of prostate cancer in different zones: a quantitative comparison
J. Gao, Q. Zhang, C. Zhang, M. Chen, D. Li, Y. Fu, X. Lv, B. Zhang, H. Guo
Clinical Radiology.2019; 74(11): 895.e17. CrossRef
Ability of Radiomics in Differentiation of Anaplastic Oligodendroglioma From Atypical Low-Grade Oligodendroglioma Using Machine-Learning Approach
Yang Zhang, Chaoyue Chen, Yangfan Cheng, Yuen Teng, Wen Guo, Hui Xu, Xuejin Ou, Jian Wang, Hui Li, Xuelei Ma, Jianguo Xu
Frontiers in Oncology.2019;[Epub] CrossRef
The Diagnostic Value of Radiomics-Based Machine Learning in Predicting the Grade of Meningiomas Using Conventional Magnetic Resonance Imaging: A Preliminary Study
Chaoyue Chen, Xinyi Guo, Jian Wang, Wen Guo, Xuelei Ma, Jianguo Xu
Frontiers in Oncology.2019;[Epub] CrossRef

13,509 View
406 Download
61 Web of Science
60 Crossref

Nomogram Development and External Validation for Predicting the Risk of Lymph Node Metastasis in T1 Colorectal Cancer: Jung Ryul Oh, Boram Park, Seongdae Lee, Kyung Su Han, Eui-Gon Youk, Doo-Han Lee, Do-Sun Kim, Doo-Seok Lee, Chang Won Hong, Byung Chang Kim, Bun Kim, Min Jung Kim, Sung Chan Park, Dae Kyung Sohn, Hee Jin Chang, Jae Hwan Oh; Cancer Res Treat. 2019;51(4):1275-1284. Published online January 17, 2019; DOI: https://doi.org/10.4143/crt.2018.569

Abstract PDF Supplementary Material PubReader ePub

Purpose
Predicting lymph node metastasis (LNM) risk is crucial in determining further treatment strategies following endoscopic resection of T1 colorectal cancer (CRC). This study aimed to establish a new prediction model for the risk of LNM in T1 CRC patients.
Materials and Methods
The development set included 833 patients with T1 CRC who had undergone endoscopic (n=154) or surgical (n=679) resection at the National Cancer Center. The validation set included 722 T1 CRC patients who had undergone endoscopic (n=249) or surgical (n=473) resection at Daehang Hospital. A logistic regression model was used to construct the prediction model. To assess the performance of prediction model, discrimination was evaluated using the receiver operating characteristic (ROC) curves with area under the ROC curve (AUC), and calibration was assessed using the Hosmer-Lemeshow (HL) goodness-of-fit test.
Results
Five independent risk factors were determined in the multivariable model, including vascular invasion, high-grade histology, submucosal invasion, budding, and background adenoma. In final prediction model, the performance of the model was good that the AUC was 0.812 (95% confidence interval [CI], 0.770 to 0.855) and the HL chi-squared test statistic was 1.266 (p=0.737). In external validation, the performance was still good that the AUC was 0.771 (95% CI, 0.708 to 0.834) and the p-value of the HL chi-squared test was 0.040. We constructed the nomogram with the final prediction model.
Conclusion
We presented an externally validated new prediction model for LNM risk in T1 CRC patients, guiding decision making in determining whether additional surgery is required after endoscopic resection of T1 CRC.

Citations

Citations to this article as recorded by

Risk stratification scores for lymph node metastases in T1 colorectal cancer—A systematic review
Rakesh Quinn, Giuleta Jamsari, Ewan MacDermid
Colorectal Disease.2025;[Epub] CrossRef
The critical role of tumor size in predicting lymph node metastasis in early-stage colorectal cancer
Attila Ulkucu, Metincan Erkaya, Ekin Inal, Emre Gorgun
The American Journal of Surgery.2025; 241: 116152. CrossRef
Pitfalls during histological assessment in locally resected pT1 colorectal cancer
Emma J Norton, Adrian C Bateman
Histopathology.2025; 87(3): 357. CrossRef
Artificial intelligence-based model to predict recurrence after local excision in T1 rectal cancer
Jiarui Su, Zhiyuan Liu, Haiming Li, Li Kang, Kaihong Huang, Jiawei Wu, Han Huang, Fei Ling, Xueqing Yao, Chengzhi Huang
European Journal of Surgical Oncology.2025; 51(6): 109717. CrossRef
Prediction of lymph node metastasis in stage I–III colon cancer patients younger than 40 years
Wei-Hao Zhang, Meng-Di Huang, Yan-Ling Tu, Kun-Zhai Huang, Chao-Jun Wang, Zhao-Hui Liu, Rui-Sheng Ke
Clinical and Translational Oncology.2025; 27(9): 3679. CrossRef
Tumor Budding as a Risk Factor for Lymph Node Metastasis and Local Recurrence in pT1 Colorectal Cancer: A Systematic Review and Meta-Analysis
Heng Zhang, Femke Simmer, Alessandro Lugli, Iris D. Nagtegaal
Gastro Hep Advances.2025; 4(9): 100713. CrossRef
Deep learning model for predicting lymph node metastasis around rectal cancer based on rectal tumor core area and mesangial imaging features
Lili Guo, Kuang Fu, Wenjia Wang, Li Zhou, Lu Chen, Miaomiao Jiang
BMC Medical Imaging.2025;[Epub] CrossRef
Evaluation of the utility of a nomogram for predicting lymph node metastasis in T1 colorectal cancer in shared decision-making in clinical practice: a survey-based study
Hyeon Seung Kim, Kyung Su Han, Min Wan Lee, Dae Kyung Sohn, Chang Won Hong, Dong Woon Lee, Kiho You, Sung Chan Park, Byung Chang Kim, Bun Kim, Jae Hwan Oh
Annals of Coloproctology.2025; 41(4): 303. CrossRef
Does Omitting Additional Surgery After Local Resection Affect Oncological Outcomes in Patients with High-Risk pT1 Colorectal Cancer?
Begoña Oronoz, Javier Suárez, Susana Oquiñena, Maria Concepción Llanos, Ana Borda, Enrique Balen
Journal of Gastrointestinal Cancer.2025;[Epub] CrossRef
From endoscopy to surgery: a translational perspective on early esophageal cancer management
Ming-xing Pan, Li-na Sun, Mei-ling Su, Yan-li Xiu
Frontiers in Medicine.2025;[Epub] CrossRef
Current Management of T1 Colon Cancer in Denmark
Anders L. Ebbehøj, Lars N. Jørgensen, Henry G. Smith, Peter-Martin Krarup
Annals of Surgery.2025; 282(6): 1110. CrossRef
Development and explanation of a machine learning model for identifying non-localized early-onset T1 colorectal cancer
Yin Zhang, Fuzhou Han, Mingyu Zheng, Duo Xu, Nan Yao, Wenqiang Li, Jun Qu
Discover Oncology.2025;[Epub] CrossRef
Risk assessment in pT1 colorectal cancer
Emma Jane Norton, Adrian C Bateman
Journal of Clinical Pathology.2024; 77(4): 225. CrossRef
Curative criteria for endoscopic treatment of colorectal cancer
Lucille Quénéhervé, Mathieu Pioche, Jérémie Jacques
Best Practice & Research Clinical Gastroenterology.2024; 68: 101883. CrossRef
Commentary: An artificial intelligence prediction model outperforms conventional guidelines in predicting lymph node metastasis of T1 colorectal cancer
Katsuro Ichimasa, Shin-ei Kudo, Khay Guan Yeoh
Frontiers in Oncology.2024;[Epub] CrossRef
Management after non-curative endoscopic resection of T1 rectal cancer
Hao Dang, Daan A. Verhoeven, Jurjen J. Boonstra, Monique E. van Leerdam
Best Practice & Research Clinical Gastroenterology.2024; 68: 101895. CrossRef
A clinical-radiomics nomogram based on spectral CT multi-parameter images for preoperative prediction of lymph node metastasis in colorectal cancer
Qian Li, Rui Hong, Ping Zhang, Liting Hou, Hailun Bao, Lin Bai, Jian Zhao
Clinical & Experimental Metastasis.2024; 41(5): 639. CrossRef
A new clinical model for predicting lymph node metastasis in T1 colorectal cancer
Kai Wang, Hui He, Yanyun Lin, Yanhong Zhang, Junguo Chen, Jiancong Hu, Xiaosheng He
International Journal of Colorectal Disease.2024;[Epub] CrossRef
Predictors of early colorectal cancer metastasis to lymph nodes: providing rationale for therapy decisions
Xu Song, Jun Li, Jiang Zhu, Yun-Fei Kong, Yu-Hang Zhou, Zi-Kun Wang, Jin Zhang
Frontiers in Oncology.2024;[Epub] CrossRef
Approaches and considerations in the endoscopic treatment of T1 colorectal cancer
Yunho Jung
The Korean Journal of Internal Medicine.2024; 39(4): 563. CrossRef
A Nomogram for Predicting Unplanned Intraoperative Hypothermia in Patients With Colorectal Cancer Undergoing Laparoscopic Colorectal Procedures
Lupei Yan, Jingxing Tan, Hao Chen, Han Xiao, Yi Zhang, Qin Yao, Yuerong Li
AORN Journal.2023;[Epub] CrossRef
A proposal for grading the risk of lymph node metastasis after endoscopic resection of T1 colorectal cancer
Zhenghua Piao, Rong Ge, Chunnian Wang
International Journal of Colorectal Disease.2023;[Epub] CrossRef
Nomogram as a novel predictive tool for lymph node metastasis in T1 colorectal cancer treated with endoscopic resection: a nationwide, multicenter study
Yoshiki Kajiwara, Shiro Oka, Shinji Tanaka, Takahiro Nakamura, Shoichi Saito, Yosuke Fukunaga, Manabu Takamatsu, Hiroshi Kawachi, Kinichi Hotta, Hiroaki Ikematsu, Motohiro Kojima, Yutaka Saito, Masayoshi Yamada, Yukihide Kanemitsu, Shigeki Sekine, Shinji
Gastrointestinal Endoscopy.2023; 97(6): 1119. CrossRef
CT morphological features for predicting the risk of lymph node metastasis in T1 colorectal cancer
Suyun Li, Zhenhui Li, Li Wang, Mimi Wu, Xiaobo Chen, Chutong He, Yao Xu, Mengyi Dong, Yanting Liang, Xin Chen, Zaiyi Liu
European Radiology.2023; 33(10): 6861. CrossRef
Prediction model for lymph node metastasis in superficial colorectal cancer: a better choice than computed tomography
Chao-Tao Tang, Jun Li, Peng Wang, You-Xiang Chen, Chun-Yan Zeng
Surgical Endoscopy.2023; 37(10): 7444. CrossRef
Lymph Node Molecular Analysis with OSNA Enables the Identification of pT1 CRC Patients at Risk of Recurrence: A Multicentre Study
Karmele Saez de Gordoa, Maria Teresa Rodrigo-Calvo, Ivan Archilla, Sandra Lopez-Prades, Alba Diaz, Jordi Tarragona, Isidro Machado, Juan Ruiz Martín, Diana Zaffalon, Maria Daca-Alvarez, Maria Pellisé, Jordi Camps, Miriam Cuatrecasas
Cancers.2023; 15(22): 5481. CrossRef
Prediction of disease recurrence or residual disease after primary endoscopic resection of pT1 colorectal cancer—results from a large nationwide Danish study
Ilze Ose, Katarina Levic, Lau Caspar Thygesen, Orhan Bulut, Thue Bisgaard, Ismail Gögenur, Tine Plato Kuhlmann
International Journal of Colorectal Disease.2023;[Epub] CrossRef
Endoscopic resection alone as a potential treatment method for low-risk deep invasive T1 colorectal cancer
Yuta Kouyama, Shin-ei Kudo, Katsuro Ichimasa, Shingo Matsudaira, Yushi Ogawa, Kenichi Mochizuki, Yuki Takashina, Yuta Sato, Tatsuya Sakurai, Yasuharu Maeda, Hiroki Nakamura, Masashi Misawa, Yuichi Mori, Toyoki Kudo, Takemasa Hayashi, Kunihiko Wakamura, Te
iGIE.2023; 2(4): 503. CrossRef
A Retrospective Multicenter Study of Risk Factors, Stratification, and Prognosis of Lymph Node Metastasis in T1 and T2 Colorectal Cancer
Eui Myung Kim, Il Tae Son, Byung Chun Kim, Jun Ho Park, Byung Mo Kang, Jong Wan Kim
Journal of Clinical Medicine.2023; 12(24): 7744. CrossRef
Risk and Time Pattern of Recurrences After Local Endoscopic Resection of T1 Colorectal Cancer: A Meta-analysis
Hao Dang, Nik Dekkers, Saskia le Cessie, Jeanin E. van Hooft, Monique E. van Leerdam, Philip P. Oldenburg, Louis Flothuis, Jan W. Schoones, Alexandra M.J. Langers, James C.H. Hardwick, Jolein van der Kraan, Jurjen J. Boonstra
Clinical Gastroenterology and Hepatology.2022; 20(2): e298. CrossRef
Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
Xinxin Cheng, Yaxin Lu, Sai Chen, Weilin Yang, Bo Xu, Jianyong Zou, Zhenguang Chen
Annals of Surgical Oncology.2022; 29(1): 598. CrossRef
Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: Systematic review
Katsuro Ichimasa, Shin‐ei Kudo, Hideyuki Miyachi, Yuta Kouyama, Kenichi Mochizuki, Yuki Takashina, Yasuharu Maeda, Yuichi Mori, Toyoki Kudo, Yuki Miyata, Yoshika Akimoto, Yuki Kataoka, Takafumi Kubota, Tetsuo Nemoto, Fumio Ishida, Masashi Misawa
Digestive Endoscopy.2022; 34(5): 901. CrossRef
Tumor Location as a Prognostic Factor in T1 Colorectal Cancer
Katsuro Ichimasa, Shin-ei Kudo, Yuta Kouyama, Kenichi Mochizuki, Yuki Takashina, Masashi Misawa, Yuichi Mori, Takemasa Hayashi, Kunihiko Wakamura, Hideyuki Miyachi
Journal of the Anus, Rectum and Colon.2022; 6(1): 9. CrossRef
Identification of Predictive Factors for Lymph Node Metastasis in pT1 Stage Colorectal Cancer Patients: A Retrospective Analysis Based on the Population Database
Jiawei Song, Huanhuan Yin, Yong Zhu, Shengqi Fei
Pathology and Oncology Research.2022;[Epub] CrossRef
Establishment of a Dynamic Nomogram for Predicting the Risk of Lymph Node Metastasis in T1 Stage Colorectal Cancer
Zitao Liu, Chao Huang, Huakai Tian, Yu Liu, Yongshan Huang, Zhengming Zhu
Frontiers in Surgery.2022;[Epub] CrossRef
Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis
Liselotte W. Zwager, Barbara A.J. Bastiaansen, Nahid S.M. Montazeri, Roel Hompes, Valeria Barresi, Katsuro Ichimasa, Hiroshi Kawachi, Isidro Machado, Tadahiko Masaki, Weiqi Sheng, Shinji Tanaka, Kazutomo Togashi, Chihiro Yasue, Paul Fockens, Leon M.G. Moo
Gastroenterology.2022; 163(1): 174. CrossRef
Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer
Jeong-ki Kim, Ye-Young Rhee, Jeong Mo Bae, Jung Ho Kim, Seong-Joon Koh, Hyun Jung Lee, Jong Pil Im, Min Jung Kim, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park, Ji Won Park, Gyeong Hoon Kang
BMC Cancer.2022;[Epub] CrossRef
Lymph node metastasis in T1 colorectal cancer with the only high-risk histology of submucosal invasion depth ≥ 1000 μm
Yusuke Yamaoka, Akio Shiomi, Hiroyasu Kagawa, Hitoshi Hino, Shoichi Manabe, Kai Chen, Kenji Nanishi, Akifumi Notsu
International Journal of Colorectal Disease.2022; 37(11): 2387. CrossRef
Subpopulation analysis of survival in high-risk T1 colorectal cancer: surgery versus endoscopic resection only
Ryun Kyong Ha, Boram Park, Kyung Su Han, Dae Kyung Sohn, Chang Won Hong, Byung Chang Kim, Bun Kim, Sung Chan Park, Hee Jin Chang, Jae Hwan Oh
Gastrointestinal Endoscopy.2022; 96(6): 1036. CrossRef
Preoperative prediction of lymph node status in patients with colorectal cancer. Developing a predictive model using machine learning
Morten Hartwig, Karoline Bendix Bräuner, Rasmus Vogelsang, Ismail Gögenur
International Journal of Colorectal Disease.2022; 37(12): 2517. CrossRef
Preoperative Predictors of Lymph Node Metastasis in Colon Cancer
Yansong Xu, Yi Chen, Chenyan Long, Huage Zhong, Fangfang Liang, Ling-xu Huang, Chuanyi Wei, Shaolong Lu, Weizhong Tang
Frontiers in Oncology.2021;[Epub] CrossRef
LASSO-Based Machine Learning Algorithm for Prediction of Lymph Node Metastasis in T1 Colorectal Cancer
Jeonghyun Kang, Yoon Jung Choi, Im-kyung Kim, Hye Sun Lee, Hogeun Kim, Seung Hyuk Baik, Nam Kyu Kim, Kang Young Lee
Cancer Research and Treatment.2021; 53(3): 773. CrossRef
Risk Stratification of T1 Colorectal Cancer Metastasis to Lymph Nodes: Current Status and Perspective
Katsuro Ichimasa, Shin-ei Kudo, Hideyuki Miyachi, Yuta Kouyama, Masashi Misawa, Yuichi Mori
Gut and Liver.2021; 15(6): 818. CrossRef
Supervised Learning Based Systemic Inflammatory Markers Enable Accurate Additional Surgery for pT1NxM0 Colorectal Cancer: A Comparative Analysis of Two Practical Prediction Models for Lymph Node Metastasis
Jinlian Jin, Haiyan Zhou, Shulin Sun, Zhe Tian, Haibing Ren, Jinwu Feng
Cancer Management and Research.2021; Volume 13: 8967. CrossRef
Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer
Kaibo Guo, Yuqian Feng, Li Yuan, Harpreet S. Wasan, Leitao Sun, Minhe Shen, Shanming Ruan
Cancer Medicine.2020; 9(14): 5095. CrossRef
Development and external validation of a predictive scoring system associated with metastasis of T1‐2 colorectal tumors to lymph nodes
Shaobo Mo, Zheng Zhou, Weixing Dai, Wenqiang Xiang, Lingyu Han, Long Zhang, Renjie Wang, Sanjun Cai, Qingguo Li, Guoxiang Cai
Clinical and Translational Medicine.2020; 10(1): 275. CrossRef
Inverse Association of Age with Risk of Lymph Node Metastasis in Superficial Colorectal Cancer: A Large Population-Based Study
Qing-Wei Zhang, Long-Ci Sun, Chao-Tao Tang, Qian Liang, Yang-Yang Zhou, Hui-Min Chen, Yun-Jie Gao, Zhi-Zheng Ge
The Oncologist.2020; 25(6): e920. CrossRef
T1 colorectal cancers: The impact of screening programs on a curable disease
Adriana Vaz Safatle-Ribeiro
Digestive and Liver Disease.2020; 52(8): 918. CrossRef
Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies
Wei Xu, Yazhou He, Yuming Wang, Xue Li, Jane Young, John P. A. Ioannidis, Malcolm G. Dunlop, Evropi Theodoratou
BMC Medicine.2020;[Epub] CrossRef

12,404 View
401 Download
50 Web of Science
49 Crossref

Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer: A Multicenter Validation Study: Joo Ho Lee, Eui Kyu Chie, Seung-Yong Jeong, Tae-You Kim, Dae Yong Kim, Tae Hyun Kim, Sun Young Kim, Ji Yeon Baek, Hee Jin Chang, Min Ju Kim, Sung Chan Park, Jae Hwan Oh, Sung Hwan Kim, Jong Hoon Lee, Doo Ho Choi, Hee Chul Park, Sung-Bum Kang, Jae-Sung Kim; Cancer Res Treat. 2018;50(2):506-517. Published online May 24, 2017; DOI: https://doi.org/10.4143/crt.2016.607

Abstract PDF PubReader ePub

Purpose
This study was conducted to validate the prognostic influence of treatment response among patients with positive circumferential resection margin for locally advanced rectal cancer.
Materials and Methods
Clinical data of 197 patientswith positive circumferentialresection margin defined as ≤ 2 mm after preoperative chemoradiotherapy followed by total mesorectal excision between 2004 and 2009were collected forthis multicenter validation study. All patients underwent median 50.4Gy radiationwith concurrentfluoropyrimidine based chemotherapy. Treatmentresponse was dichotomized to good response, including treatmentresponse of grade 2 or 3, and poor response, including grade 0 or 1.
Results
After 52 months median follow-up, 5-year overall survival (OS) for good responders and poor responders was 79.1% and 48.4%, respectively (p < 0.001). In multivariate analysis, circumferential resection margin involvement and treatment response were a prognosticator for OS and locoregional recurrence-free survival. In subgroup analysis, good responders with close margin showed significantly better survival outcomes for survival. Good responders with involved margin and poor responders with close margin shared similar results, whereas poorresponderswith involved margin hadworst survival (5-year OS, 81.2%, 57.0%, 50.0%, and 32.4%, respectively; p < 0.001).
Conclusion
Among patients with positive circumferential resection margin after preoperative chemoradiotherapy, survival of the good responders was significantly better than poor responders. Subgroup analysis revealed that definition of positive circumferential resection margin may be individualized as involvement for good responders, whereas ≤ 2 mm for poor responders.

Citations

Citations to this article as recorded by

Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR 4): Long-term Results From a Multicenter, Randomized, Open-Label, Phase II Trial
Philippe Rouanet, Eric Rullier, Bernard Lelong, Philippe Maingon, Jean-Jacques Tuech, Denis Pezet, Florence Castan, Stephanie Nougaret
Diseases of the Colon & Rectum.2022; 65(8): 986. CrossRef
Colorectal Cancer Surgery Quality in Manitoba: A Population-Based Descriptive Analysis
Iresha Ratnayake, Jason Park, Natalie Biswanger, Allison Feely, Grace Musto, Kathleen Decker
Current Oncology.2021; 28(3): 2239. CrossRef

12,531 View
266 Download
4 Web of Science
2 Crossref

What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?: Soo Hee Kim, Hee Jin Chang, Dae Yong Kim, Ji Won Park, Ji Yeon Baek, Sun Young Kim, Sung Chan Park, Jae Hwan Oh, Ami Yu, Byung-Ho Nam; Cancer Res Treat. 2016;48(3):998-1009. Published online October 22, 2015; DOI: https://doi.org/10.4143/crt.2015.254

Abstract PDF PubReader ePub

Purpose
Tumor regression grade (TRG) is predictive of therapeutic response in rectal cancer patients after chemoradiotherapy (CRT) followed by curative resection. However, various TRG systems have been suggested, with subjective categorization, resulting in interobserver variability. This study compared the prognostic validity of four different TRG systems in order to identify the most ideal TRG system. Materials and Methods This study included 933 patients who underwent preoperative CRT and curative resection. Primary tumors alone were graded according to the American Joint Committee on Cancer (AJCC), Dworak, and Ryan TRG systems, and both primary tumors and regional lymph nodes were graded according to a modified Dworak TRG system. The ability of each TRG system to predict recurrence-free survival (RFS) and overall survival (OS) was analyzed using chisquare and C statistics.
Results
All four TRG systems were significantly predictive of both RFS and OS (p < 0.001 each), however none was a better predictor of prognosis than ypStage. Among the four TRGs, the mDworak TRG system was a better predictor of RFS and OS than the AJCC, Dworak, and Ryan TRG systems, and both the chi-square and C statistics were higher for the former, although the differences were not statistically significant. The combination of ypStage and the modified Dworak TRG better predicted RFS and OS than ypStage alone. Conclusion The modified Dworak TRG system for evaluation of entire tumors including regional lymph nodes is a better predictor of survival than current TRG systems for evaluation of the primary tumor alone.

Citations

Citations to this article as recorded by

Neoadjuvant chemotherapy in locally advanced colon cancer: A systematic review with proportional meta-analysis
K. van den Berg, I.E.G. van Hellemond, J.M.W.E. Willems, J.W.A. Burger, H.J.T. Rutten, G.J. Creemers
European Journal of Surgical Oncology.2025; 51(3): 109560. CrossRef
Prognostic Value of Tumor Regression Grade Combined with Pathological Lymph Node Status in Initially Node-Positive Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
Dakui Luo, Yajie Chen, Zhouyu Luo, Huangbo Gong, Qingguo Li, Xinxiang Li
Journal of Investigative Surgery.2025;[Epub] CrossRef
Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with two step feature selection and ensemble learning
Changshun Qian, Shuxin Yang, Yijing Chen, Ran Ge, Fangmin Shi, Chengnan Liu, Hui Wang, You Guo
Scientific Reports.2025;[Epub] CrossRef
Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: long-term results of a randomized controlled trial
Mahdi Aghili, Mohammad-Mahdi Aghaei, Romina Abyaneh, Mohammad Babaei, Farshid Farhan, Marzieh Lashkari, Borna Farazmand, Kasra Kolahdouzan, Guglielmo Niccolò Piozzi, Felipe Counago, Reza Ghalehtaki
International Journal of Colorectal Disease.2025;[Epub] CrossRef
Controversies and Perspectives in the Current Management of Patients with Locally Advanced Rectal Cancer—A Systematic Review
Roxana Elena Stefan, Rodica Daniela Birla, Mircea Gheorghe, Daniela Elena Dinu, Petre Angel Hoara, Diana Ciuc, Valeriu-Gabi Dinca, Silviu Constantinoiu
Life.2025; 15(7): 1011. CrossRef
Metformin’s impact on tumor regression grade in diabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
Nai-Yu Lin, Kun-Yu Tsai, Yen-Lin Huang, Bor-Kang Jong, Zhen-Hao Yu, Ching-Chung Cheng, Shu-Huan Huang, Jeng-Fu You, I-Li Lai
Scientific Reports.2025;[Epub] CrossRef
How best to combine DWI and T2WI to predict pathologic complete response: a multi-center study on interpreting MRI following chemoradiotherapy of rectal cancer
Hae Young Kim, Nieun Seo, Soon Nam Oh, Sung Kyoung Moon, Chul-min Lee, Jong Keon Jang, Bohyun Kim, Seung Hyun Cho, Jun Seok Park, Seong Ho Park, Joon Seok Lim
European Radiology.2025;[Epub] CrossRef
Predicting neoadjuvant chemoradiotherapy response in rectal cancer: Insights from biomarkers to clinical practice
Hikmet Pehlevan-Özel, Eda Şahingöz, Mert Altaş, Mesut Tez
World Journal of Gastrointestinal Surgery.2025;[Epub] CrossRef
Correlation Between MRI and Histopathology in Assessing Treatment Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
Pedram Fadavi, Kambiz Novin, Maryam Garousi, Amir Mohammad Arefpour, Seyedeh Shaghayegh Rezvani Nezhad, Mahshid Soori, Farzad Taghizadeh‐Hesary
Cancer Reports.2025;[Epub] CrossRef
A20 Facilitates Oxaliplatin Sensitivity in Colorectal Cancer Through Monoubiquitylation of IKK‐β
Fan Luo, Ting Yang, Jiaxin Cao, Qun Chen, Zhenhai Lu, Feiteng Lu, Chaozhuo Lin, Zengfei Xia, Yuanzhong Yang, Peng Li, Wenjuan Ma, Min Luo, Rongxin Zhang
Advanced Science.2025;[Epub] CrossRef
Interpretation of Complete Tumor Response on MRI Following Chemoradiotherapy of Rectal Cancer: Inter-Reader Agreement and Associated Factors in Multi-Center Clinical Practice
Hae Young Kim, Seung Hyun Cho, Jong Keon Jang, Bohyun Kim, Chul-min Lee, Joon Seok Lim, Sung Kyoung Moon, Soon Nam Oh, Nieun Seo, Seong Ho Park
Korean Journal of Radiology.2024; 25(4): 351. CrossRef
Evaluating complete response prediction rates in locally advanced rectal cancer with different radiomics segmentation approaches
Gizem Kaval, Merve Gulbiz Dagoglu Kartal, Sena Azamat, Eda Cingoz, Gokhan Ertas, Sule Karaman, Basak Kurtuldu, Metin Keskin, Neslihan Berker, Senem Karabulut, Ethem Nezih Oral, Nergiz Dagoglu Sakin
Pathology and Oncology Research.2024;[Epub] CrossRef
Regressionsgrading gastrointestinaler Tumoren
Doreen Maria Gisder, Andrea Tannapfel, Iris Tischoff
Die Gastroenterologie.2024; 19(3): 234. CrossRef
Rectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy
Nathan M. Kohrman, Jordan R. Wlodarczyk, Li Ding, Nicholas P. McAndrew, Sandra D. Algaze, Kyle G. Cologne, Sang W. Lee, Sarah E. Koller
Diseases of the Colon & Rectum.2024; 67(7): 920. CrossRef
Predictive value of flexible proctosigmoidoscopy and laboratory findings for complete clinical responses after neoadjuvant chemoradiotherapy in patients with locally advanced primary rectal cancer: a retrospective cohort study
Alireza Hadizadeh, Hamed Kazemi-Khaledi, Mohammad-Sadegh Fazeli, Seyed-Mohsen Ahmadi-Tafti, Amir Keshvari, Reza Akbari-Asbagh, Mohammad-Reza Keramati, Alireza Kazemeini, Amir-Reza Fazeli, Behnam Behboudi, Mohammadamin Parsaei
International Journal of Colorectal Disease.2024;[Epub] CrossRef
Are the tumor microenvironment characteristics of pretreatment biopsy specimens of colorectal cancer really effectively predict the efficacy of neoadjuvant therapy: A retrospective multicenter study
Bingbing Li, Longjiao Chen, Yichun Huang, Meng Wu, Weilan Fang, Xin Zou, Yihong Zheng, Qiuxiang Xiao
Medicine.2024; 103(35): e39429. CrossRef
Outcomes of rectal cancer treatment in rural Australia and New Zealand: analysis of the bowel cancer outcomes registry
Ishmam Murshed, Tessa L. Dinger, Duveke P. E. de Gaay Fortman, Luke Traeger, Sergei Bedrikovetski, Andrew Hunter, Hidde M. Kroon, Tarik Sammour
ANZ Journal of Surgery.2024; 94(10): 1823. CrossRef
Relationship Between Neoadjuvant Chemoradiotherapy Response and Mesorectum Volume in Rectum Cancer
Ramazan Saygın Kerimoğlu, Ebru Esen, Mustafa Saraçoğlu, İbrahim Babalıoğlu, Bekir Turgut, İlknur Küçükosmanoğlu, Osman Doğru
Acta Haematologica Oncologica Turcica.2024; : 44. CrossRef
Molecular Mechanism of Radioresponsiveness in Colorectal Cancer: A Systematic Review
Matthew Lau, Md Islam Khan, Helen Law
Genes.2024; 15(10): 1257. CrossRef
Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy
Jun-Eul Hwang, Sung-Sun Kim, Hyun-Jin Bang, Hyeon-Jong Kim, Hyun-Jeong Shim, Woo-Kyun Bae, Ik-Joo Chung, Eun-Gene Sun, Taebum Lee, Chan-Young Ock, Jeong-Seok Nam, Sang-Hee Cho
Cancers.2024; 16(19): 3353. CrossRef
A Novel Engineered AAV-Based Neoantigen Vaccine in Combination with Radiotherapy Eradicates Tumors
Kevin Chih-Yang Huang, Chia-Ying Lai, Wei-Ze Hung, Hsin-Yu Chang, Pei-Chun Lin, Shu-Fen Chiang, Tao-Wei Ke, Ji-An Liang, An-Cheng Shiau, Pei-Chen Yang, William Tzu-Liang Chen, K.S. Clifford Chao
Cancer Immunology Research.2023; 11(1): 123. CrossRef
Does Pathological Complete Response after Neoadjuvant Therapy Influence Postoperative Morbidity in Rectal Cancer after Transanal Total Mesorectal Excision?
Martin Svoboda, Vladimír Procházka, Tomáš Grolich, Tomáš Pavlík, Monika Mazalová, Zdeněk Kala
Journal of Gastrointestinal Cancer.2023; 54(2): 528. CrossRef
MRI‐Based Artificial Intelligence in Rectal Cancer
Chinting Wong, Yu Fu, Mingyang Li, Shengnan Mu, Xiaotong Chu, Jiahui Fu, Chenghe Lin, Huimao Zhang
Journal of Magnetic Resonance Imaging.2023; 57(1): 45. CrossRef
Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non‐responders' tumor tissue
Tamara Babic, Vasiliki Lygirou, Jovana Rosic, Marko Miladinov, Aleksandra Djikic Rom, Eirini Baira, Rafael Stroggilos, Eftychia Pappa, Jerome Zoidakis, Zoran Krivokapic, Aleksandra Nikolic
PROTEOMICS – Clinical Applications.2023;[Epub] CrossRef
Comparison of the diagnostic performance of changes in signal intensity and volume from multiparametric MRI for assessing response of rectal cancer to neoadjuvant chemoradiotherapy
Zhengwu Tan, Lan Cheng, Lingling Xie, Lan Zhang, Zhenyu Lin, Ping Han, Xin Li
Asia-Pacific Journal of Clinical Oncology.2023; 19(3): 327. CrossRef
Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy
Emese Sarolta Bádon, Lívia Beke, Attila Mokánszki, Csilla András, Gábor Méhes
International Journal of Molecular Sciences.2023; 24(3): 2581. CrossRef
Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
Hyun Jin Bang, Hyun Jeong Shim, Jun Eul Hwang, Woo Kyun Bae, Ik Joo Chung, Sang Hee Cho
Chonnam Medical Journal.2023; 59(1): 76. CrossRef
The prognostic role of tumor budding and tumor-stroma ratio in pulmonary metastasis of colorectal carcinoma
Topias Karjula, Niko Kemi, Anne Niskakangas, Olli Mustonen, Iiris Puro, Vesa-Matti Pohjanen, Teijo Kuopio, Hanna Elomaa, Maarit Ahtiainen, Jukka-Pekka Mecklin, Toni T. Seppälä, Erkki-Ville Wirta, Eero Sihvo, Juha P. Väyrynen, Fredrik Yannopoulos, Olli Hel
European Journal of Surgical Oncology.2023; 49(7): 1298. CrossRef
An investigation into tumor regression grade as a parameter for locally advanced rectal cancer and 5-year overall survival rate
Supparerk Laohawiriyakamol, Wongsakorn Chaochankit, Worawit Wanichsuwan, Kanet Kanjanapradit, Teeranan Laohawiriyakamol
Annals of Coloproctology.2023; 39(1): 59. CrossRef
Deep learning of endoscopic features for the assessment of neoadjuvant therapy response in locally advanced rectal cancer
Anqi Wang, Jieli Zhou, Gang Wang, Beibei Zhang, Hongyi Xin, Haiyang Zhou
Asian Journal of Surgery.2023; 46(9): 3568. CrossRef
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation
Jingjing Wu, Mingzhe Huang, Yuanhui Wu, Yisong Hong, Linbin Cai, Rongzhao He, Yanxin Luo, Puning Wang, Meijin Huang, Jinxin Lin
Journal of Cancer Research and Clinical Oncology.2023; 149(11): 8897. CrossRef
A multi-class classification algorithm based on hematoxylin-eosin staining for neoadjuvant therapy in rectal cancer: a retrospective study
Yihan Wu, Xiaohua Liu, Fang Liu, Yi Li, Xiaomin Xiong, Hao Sun, Bo Lin, Yu Li, Bo Xu
PeerJ.2023; 11: e15408. CrossRef
Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients
Caterina Foppa, Annalisa Maroli, Antonio Luberto, Carlotta La Raja, Paola Spaggiari, Cristiana Bonifacio, Stefano De Zanet, Marco Montorsi, Salvatore Piscuoglio, Luigi Maria Terracciano, Armando Santoro, Antonino Spinelli
Cancers.2023; 15(14): 3750. CrossRef
Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
I-Li Lai, Jeng-Fu You, Wen-Sy Tsai, Yu-Jen Hsu, Yih-Jong Chern, Ming-Ying Wu
World Journal of Surgical Oncology.2023;[Epub] CrossRef
Risk factors for lateral pelvic lymph node metastasis in patients with lower rectal cancer: a systematic review and meta-analysis
De-xing Zeng, Zhou Yang, Ling Tan, Meng-ni Ran, Zi-lin Liu, Jiang-wei Xiao
Frontiers in Oncology.2023;[Epub] CrossRef
Clinical predictors of rectal cancer response after neo-adjuvant (Chemo)Radiotherapy in Australia and New Zealand: Analysis of the Bi-National Colorectal Cancer Audit (BCCA)
Jianliang Liu, Justin Y.T. Lee, Sergei Bedrikovetski, Luke Traeger, James W. Moore, Joanne L. Perry, Hidde M. Kroon, Tarik Sammour
European Journal of Surgical Oncology.2023; 49(11): 107070. CrossRef
Pancreatic ductal adenocarcinoma complete regression after preoperative chemotherapy: Surgical results in a small series
Domenico Pinelli, Andrea Micalef, Barbara Merelli, Rosangela Trezzi, Annalisa Amaduzzi, Stefano Agnesi, Michela Guizzetti, Stefania Camagni, Veronica Fedele, Michele Colledan
Cancer Treatment and Research Communications.2023; 37: 100770. CrossRef
The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0
Yujun Cui, Xinzhi Liu, Shuai Li, Hongzhi Wang, Yirong Xiang, Yangzi Zhang, Maxiaowei Song, Jianhao Geng, Zhiyan Liu, Huajing Teng, Xianggao Zhu, Yong Cai, Yongheng Li, Weihu Wang
Clinical and Translational Oncology.2023; 26(4): 1012. CrossRef
Grading der Tumorregression gastrointestinaler Karzinome nach neoadjuvanter Therapie
Drolaiz Liu, Rupert Langer
Der Pathologe.2022; 43(1): 51. CrossRef
Deeper sections reveal residual tumor cells in rectal cancer specimens diagnosed with pathological complete response following neoadjuvant treatment
Lasse Slumstrup, Susanne Eiholm, Astrid Louise Bjørn Bennedsen, Dea Natalie Munch Jepsen, Ismail Gögenur, Anne-Marie Kanstrup Fiehn
Virchows Archiv.2022; 480(5): 1041. CrossRef
MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy
Jaeseung Shin, Nieun Seo, Song-Ee Baek, Nak-Hoon Son, Joon Seok Lim, Nam Kyu Kim, Woong Sub Koom, Sungwon Kim
Radiology.2022; 303(2): 351. CrossRef
Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer
Laureline Lamy, Jacques Thomas, Agnès Leroux, Jean-François Bisson, Kari Myren, Aslak Godal, Gry Stensrud, Lina Bezdetnaya
Biomedicines.2022; 10(3): 548. CrossRef
High Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Low Lymphocyte Levels Are Correlated With Worse Pathological Complete Response Rates
Serdar Karakaya, İbrahim Karadağ, Mehmet Emin Yılmaz, Ömür Berna Çakmak Öksüzoğlu
Cureus.2022;[Epub] CrossRef
Development of a method for digital assessment of tumor regression grade in patients with rectal cancer following neoadjuvant therapy
Dea Natalie Munch Jepsen, Henrik Høeg, Jeppe Thagaard, Julie Sparholt Walbech, Ismail Gögenur, Anne-Marie Kanstrup Fiehn
Journal of Pathology Informatics.2022; 13: 100152. CrossRef
The reduction of 18F-FDG uptake ability of tumor tissue after neoadjuvant chemoradiotherapy in locally advanced rectal cancer can effectively reflect the degree of tumor regression
Fengpeng Wu, Xiaoxiao Zhang, Congrong Yang, Kanghua Wang, Linlin Xiao, Chaoxi Zhou, Xinming Zhao, Guiying Wang
Frontiers in Oncology.2022;[Epub] CrossRef
Reduced field-of-view versus full field-of-view diffusion-weighted imaging for the evaluation of complete response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
Siwon Jang, Jeong Min Lee, Jeong Hee Yoon, Jae Seok Bae
Abdominal Radiology.2021; 46(4): 1468. CrossRef
Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer
Peige Zhou, Paolo Goffredo, Timothy Ginader, Dakota Thompson, Jennifer Hrabe, Irena Gribovskaja‐Rupp, Muneera Kapadia, Imran Hassan
Journal of Surgical Oncology.2021; 123(1): 278. CrossRef
Clinical predictors of response to chemoradiotherapy for rectal cancer as an aid to organ preservation
Jesse Fischer, Tim W. Eglinton, Frank A. Frizelle
ANZ Journal of Surgery.2021; 91(6): 1190. CrossRef
Can the mesorectal fat tissue volume be used as a predictive factor in foreseeing the response to neoadjuvant chemoradiotherapy in rectum cancer? A CT-based preliminary study
Okan Dilek, Huseyin Akkaya, Cenk Parlatan, Tolga Koseci, Zeynel Abidin Tas, Gökhan Soker, Bozkurt Gulek
Abdominal Radiology.2021; 46(6): 2415. CrossRef
Pathological response post neoadjuvant therapy for locally advanced rectal cancer is an independent predictor of survival
Jason On, Joanna Shim, Craig Mackay, Graeme Murray, Leslie Samuel, Craig Parnaby, George Ramsay
Colorectal Disease.2021; 23(6): 1326. CrossRef
Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review
K. Wilson, M. Flood, V. Narasimhan, T. Pham, S. Warrier, R. Ramsay, M. Michael, A. Heriot
European Journal of Surgical Oncology.2021; 47(8): 1862. CrossRef
Contemporary snapshot of tumor regression grade (TRG) distribution in locally advanced rectal cancer: a cross sectional multicentric experience
Paola Germani, Francesca Di Candido, Daniel Léonard, Dajana Cuicchi, Ugo Elmore, Marco Ettore Allaix, Vittoria Pia Barbieri, Laura D’Allens, Seraina Faes, Marika Milani, Damiano Caputo, Carmen Martinez, Jan Grosek, Valerio Caracino, Niki Christou, Sapho X
Updates in Surgery.2021; 73(5): 1795. CrossRef
The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study
Yanting Liang, Yaxi Zhu, Huan Lin, Shenyan Zhang, Suyun Li, Yanqi Huang, Chen Liu, Jinrong Qu, Changhong Liang, Ke Zhao, Zhenhui Li, Zaiyi Liu
BMC Cancer.2021;[Epub] CrossRef
Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?
Yuho Ono, Justin M.M. Cates, Raul S. Gonzalez
Pathology - Research and Practice.2021; 226: 153608. CrossRef
A 41-Gene Pair Signature for Predicting the Pathological Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation
Zhengfa Xue, Shuxin Yang, Yun Luo, Hao Cai, Ming He, Youping Ding, Lei Lei, Wei Peng, Guini Hong, You Guo
Frontiers in Medicine.2021;[Epub] CrossRef
Validation of Gene Expression-Based Predictive Biomarkers for Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Tomoyuki Momma, Hirokazu Okayama, Yasuyuki Kanke, Satoshi Fukai, Hisashi Onozawa, Shotaro Fujita, Wataru Sakamoto, Motonobu Saito, Shinji Ohki, Koji Kono
Cancers.2021; 13(18): 4642. CrossRef
Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey
Maria Westerhoff, Marek Osecky, Rupert Langer
Modern Pathology.2020; 33(4): 676. CrossRef
Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancer
Toshiki Mukai, Keisuke Uehara, Toshisada Aiba, Atsushi Ogura, Toyonori Tsuzuki, Aya Tanaka, Masanori Sando, Noriyuki Ohara, Yusuke Sato, Norifumi Hattori, Goro Nakayama, Yasuhiro Kodera, Masato Nagino
Surgery Today.2020; 50(8): 912. CrossRef
The Effect of Lymph Nodes’ Histologic Response on Survival Outcomes in Moroccan Patients with Rectal Cancer
Ihsane El Otmani, Fatima El Agy, Mohammed El Abkari, Karim Ibn Majdoub Hassani, Khalid Mazaz, El Bachir Benjelloun, Khalid Ait Taleb, Touria Bouhafa, Zineb Benbrahim, Sidi Adil Ibrahimi, Laila Chbani
International Journal of Surgical Oncology.2020; 2020: 1. CrossRef
Prognostic Value of Tumor Regression Grade Based on Ryan Score in Squamous Cell Carcinoma and Adenocarcinoma of Esophagus
Flávio Roberto Takeda, Francisco Tustumi, Carlos de Almeida Obregon, Gustavo Gonçalves Yogolare, Yasmin Peres Navarro, Vanderlei Segatelli, Rubens Antonio Aissar Sallum, Ulysses Ribeiro Junior, Ivan Cecconello
Annals of Surgical Oncology.2020; 27(4): 1241. CrossRef
Standardized Pathology Report for Colorectal Cancer, 2nd Edition
Baek-hui Kim, Joon Mee Kim, Gyeong Hoon Kang, Hee Jin Chang, Dong Wook Kang, Jung Ho Kim, Jeong Mo Bae, An Na Seo, Ho Sung Park, Yun Kyung Kang, Kyung-Hwa Lee, Mee Yon Cho, In-Gu Do, Hye Seung Lee, Hee Kyung Chang, Do Youn Park, Hyo Jeong Kang, Jin Hee So
Journal of Pathology and Translational Medicine.2020; 54(1): 1. CrossRef
Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer
Jason K. Douglas, Rose E. Callahan, Zachary A. Hothem, Craig S. Cousineau, Samer Kawak, Bryan J. Thibodeau, Shelli Bergeron, Wei Li, Claire E. Peeples, Harry J. Wasvary
Molecular & Cellular Oncology.2020; 7(3): 1716618. CrossRef
53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer
Ai Huang, Yong Xiao, Chunfen Peng, Tao Liu, Zhenyu Lin, Qin Yang, Tao Zhang, Jun Liu, Hong Ma
Strahlentherapie und Onkologie.2020; 196(5): 465. CrossRef
Predictors of pathological response and clinical outcome following chemoradiation for locally advanced rectal cancer — a systematic review
Erica Amaral, Maria Bernardes, Sara Ribeiro, Beatriz Rosa, Ana Pereira, Sandra F. Martins
Journal of Coloproctology.2020; 40(03): 278. CrossRef
The effect of radiotherapy on rectal cancer: a histopathological appraisal and prognostic indicators
Mohammad AlQudah, Emil Salmo, Najib Haboubi
Radiation Oncology Journal.2020; 38(2): 77. CrossRef
Short-course versus long-course neoadjuvant chemoradiotherapy in patients with rectal cancer: preliminary results of a randomized controlled trial
Mahdi Aghili, Nastaran Khalili, Neda Khalili, Mohammad Babaei, Farshid Farhan, Peiman Haddad, Samaneh Salarvand, Amir Keshvari, Mohammad Sadegh Fazeli, Negin Mohammadi, Reza Ghalehtaki
Radiation Oncology Journal.2020; 38(2): 119. CrossRef
Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study
Bianca Petresc, Andrei Lebovici, Cosmin Caraiani, Diana Sorina Feier, Florin Graur, Mircea Marian Buruian
Cancers.2020; 12(7): 1894. CrossRef
Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy

Siyi Lu, Zhenzhen Liu, Xin Zhou, Bingyan Wang, Fei Li, Yanpeng Ma, Wendong Wang, Junren Ma, Yuxia Wang, Hao Wang, Wei Fu
Cancer Management and Research.2020; Volume 12: 8555. CrossRef
Staging of Locally Advanced Rectal Cancer Beyond TME
Deborah S. Keller
Clinics in Colon and Rectal Surgery.2020; 33(05): 258. CrossRef
Tumor Regression in Lymph Node Metastases of Esophageal Adenocarcinomas after Neoadjuvant Therapy
Marek Osecky, Dino Kröll, Marcus Feith, Daniel Reim, Bastian Dislich, Karen Becker, Rupert Langer
Gastrointestinal Disorders.2020; 2(4): 397. CrossRef
Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer
Chinock Cheong, Jun Sang Shin, Kwang Wook Suh
World Journal of Gastroenterology.2020; 26(44): 7022. CrossRef
MicroRNA Profiling in Oesophageal Adenocarcinoma Cell Lines and Patient Serum Samples Reveals a Role for miR-451a in Radiation Resistance
Frederike Butz, Ann-Kathrin Eichelmann, George C. Mayne, Tingting Wang, Isabell Bastian, Karen Chiam, Shashikanth Marri, Pamela J. Sykes, Bas P. Wijnhoven, Eelke Toxopeus, Michael Z. Michael, Christos S. Karapetis, Richard Hummel, David I. Watson, Damian
International Journal of Molecular Sciences.2020; 21(23): 8898. CrossRef
Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer
Heyu Song, Jiping Zeng, Shrabasti Roychoudhury, Pranjal Biswas, Bhopal Mohapatra, Sutapa Ray, Kayvon Dowlatshahi, Jing Wang, Vimla Band, Geoffrey Talmon, Kishor K. Bhakat
Molecular Cancer Therapeutics.2020; 19(1): 258. CrossRef
Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy
Jung Wook Huh, Hee Cheol Kim, Seok Hyung Kim, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Hee Chul Park, Doo Ho Choi, Joon Oh Park, Young Suk Park, Ho-Kyung Chun
Surgery.2019; 165(3): 579. CrossRef
Tumour regression after radiotherapy for rectal cancer – Results from the randomised Stockholm III trial
Johan Erlandsson, Ester Lörinc, Madelene Ahlberg, David Pettersson, Torbjörn Holm, Bengt Glimelius, Anna Martling
Radiotherapy and Oncology.2019; 135: 178. CrossRef
Differences in prognostic relevance of rectal magnetic resonance imaging findings before and after neoadjuvant chemoradiotherapy
Kwang-Seop Song, Dong Woon Lee, Bun Kim, Bo Yun Hur, Min Jung Kim, Min Ju Kim, Chang Won Hong, Sung Chan Park, Hyoung-Chul Park, Dae Kyung Sohn, Byung Chang Kim, Kyung Su Han, Jae Hwan Oh
Scientific Reports.2019;[Epub] CrossRef
A prospective feasibility study evaluating the role of multimodality imaging and liquid biopsy for response assessment in locally advanced rectal carcinoma
Zahra Kassam, Kyle Burgers, Joanna C. Walsh, Ting-Yim Lee, Hon S. Leong, Barbara Fisher
Abdominal Radiology.2019; 44(11): 3641. CrossRef
Pretreatment Blood Biomarkers Predict Pathologic Responses to Neo-Crt in Patients with Locally Advanced Rectal Cancer
Aijie Li, Kewen He, Dong Guo, Chao Liu, Duoying Wang, Xiangkui Mu, Jinming Yu
Future Oncology.2019; 15(28): 3233. CrossRef
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis
Giuseppe N. Fanelli, Fotios Loupakis, Elizabeth Smyth, Marco Scarpa, Sara Lonardi, Salvatore Pucciarelli, Giada Munari, Massimo Rugge, Nicola Valeri, Matteo Fassan
International Journal of Surgical Pathology.2019; 27(8): 816. CrossRef
Translational Potential of MicroRNAs for Preoperative Staging and Prediction of Chemoradiotherapy Response in Rectal Cancer
Tana Machackova, Vladimir Prochazka, Zdenek Kala, Ondrej Slaby
Cancers.2019; 11(10): 1545. CrossRef
Association of tumor differentiation and prognosis in patients with rectal cancer undergoing neoadjuvant chemoradiation therapy
Qunsheng Huang, Huabo Qin, Jian Xiao, Xiaosheng He, Minghao Xie, Xin He, Qiuqiong Yao, Ping Lan, Lei Lian
Gastroenterology Report.2019; 7(4): 283. CrossRef
Prognostic value of the texture analysis parameters of the initial computed tomographic scan for response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
Benjamin Vandendorpe, Carole Durot, Loïc Lebellec, Marie-Cécile Le Deley, Dienabou Sylla, André-Michel Bimbai, Kocéila Amroun, Fabrice Ramiandrisoa, Abel Cordoba, Xavier Mirabel, Christine Hoeffel, David Pasquier, Stéphanie Servagi-Vernat
Radiotherapy and Oncology.2019; 135: 153. CrossRef
Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma
M. L. Sánchez de Molina, C. Díaz del Arco, P. Vorwald, D. García-Olmo, L. Estrada, M. J. Fernández-Aceñero
Clinical and Translational Oncology.2018; 20(2): 253. CrossRef
Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy
Rupert Langer, Karen Becker
Virchows Archiv.2018; 472(2): 175. CrossRef
Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS -mutated rectal cancer: A phase I/II trial (SAKK 41/08)
Roger von Moos, Dieter Koeberle, Sabina Schacher, Stefanie Hayoz, Ralph C. Winterhalder, Arnaud Roth, György Bodoky, Panagiotis Samaras, Martin D. Berger, Daniel Rauch, Piercarlo Saletti, Ludwig Plasswilm, Daniel Zwahlen, Urs R. Meier, Pu Yan, Paola Izzo,
European Journal of Cancer.2018; 89: 82. CrossRef
A qualitative signature for predicting pathological response to neoadjuvant chemoradiation in locally advanced rectal cancers
You Guo, Weizhong Jiang, Lu Ao, Kai Song, Huxing Chen, Qingzhou Guan, Qiao Gao, Jun Cheng, Huaping Liu, Xianlong Wang, Guoxian Guan, Zheng Guo
Radiotherapy and Oncology.2018; 129(1): 149. CrossRef
Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings
Min Ju Kim, Bo Yun Hur, Eun Sun Lee, Boram Park, Jungnam Joo, Min Jung Kim, Sung Chan Park, Ji Yeon Baek, Hee Jin Chang, Dae Yong Kim, Jae Hwan Oh, Ju-Seog Lee
PLOS ONE.2018; 13(4): e0195815. CrossRef
Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer
J K Jang, J L Lee, S H Park, H J Park, I J Park, J H Kim, S H Choi, J Kim, C S Yu, J C Kim
British Journal of Surgery.2018; 105(12): 1671. CrossRef
Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
Changhoon Song, Joo-Hyun Chung, Sung-Bum Kang, Duck-Woo Kim, Heung-Kwon Oh, Hye Seung Lee, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jae-Sung Kim
Cancers.2018; 10(9): 319. CrossRef
Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer
Karina Vychnevskaia, Frederic Dumont, Julie Agostini, Catherine Julié, Peggy Dartigues, Thierry Lazure, Valérie Boige, Diane Goéré, Antoine Brouquet, Christophe Penna, Frédérique Peschaud, Stéphane Benoist
Annals of Surgical Oncology.2017; 24(5): 1304. CrossRef
Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
Delphine Dayde, Ichidai Tanaka, Rekha Jain, Mei Tai, Ayumu Taguchi
International Journal of Molecular Sciences.2017; 18(3): 573. CrossRef
Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy
Luca Reggiani Bonetti, Simona Lionti, Federica Domati, Giuliana Pagliani, Elisabetta Mattioli, Valeria Barresi
Histopathology.2017; 71(3): 393. CrossRef
Applicability of American Joint Committee on Cancer and College of American Pathologists Regression Grading System in Rectal Cancer
Tarkan Jäger, Daniel Neureiter, Romana Urbas, Eckhard Klieser, Wolfgang Hitzl, Klaus Emmanuel, Adam Dinnewitzer
Diseases of the Colon & Rectum.2017; 60(8): 815. CrossRef
Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer
Dae Kyung Sohn, Kyung Su Han, Byung Chang Kim, Chang Won Hong, Hee Jin Chang, Ji Yeon Baek, Min Ju Kim, Sung Chan Park, Jae Hwan Oh, Dae Yong Kim
Surgical Oncology.2017; 26(4): 453. CrossRef
Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
Luca Reggiani Bonetti, Simona Lionti, Federica Domati, Valeria Barresi
World Journal of Gastroenterology.2017; 23(8): 1412. CrossRef
Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
Ombretta Repetto, Valli De Re, Antonino De Paoli, Claudio Belluco, Lara Alessandrini, Vincenzo Canzonieri, Renato Cannizzaro
Oncotarget.2017; 8(17): 28328. CrossRef
Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers
You Guo, Jun Cheng, Lu Ao, Xiangyu Li, Qingzhou Guan, Juan Zhang, Haidan Yan, Hao Cai, Qiao Gao, Weizhong Jiang, Zheng Guo
Scientific Reports.2016;[Epub] CrossRef
Analysis of long-term outcomes and application of the tumor regression grading system in the therapeutic assessment of resectable limited-disease small cell lung cancer
Shuonan Xu, Jianfei Zhu, Yawei Dou, Wei Tian, Yun Dai, Xianghui Luo, Hongtao Wang
Oncology and Translational Medicine.2016; 2(5): 227. CrossRef

29,810 View
602 Download
103 Web of Science
98 Crossref

Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer: Kyung Su Han, Dae Kyung Sohn, Dae Yong Kim, Byung Chang Kim, Chang Won Hong, Hee Jin Chang, Sun Young Kim, Ji Yeon Baek, Sung Chan Park, Min Ju Kim, Jae Hwan Oh; Cancer Res Treat. 2016;48(2):567-573. Published online September 22, 2015; DOI: https://doi.org/10.4143/crt.2015.195

Abstract PDF PubReader ePub

Purpose
Local excision may be an another option for selected patients with markedly down-staged rectal cancer after preoperative chemoradiation therapy (CRT), and proper evaluation of post-CRT tumor stage (ypT) is essential prior to local excision of these tumors. This study was designed to determine the correlations between endoscopic findings and ypT of rectal cancer.
Materials and Methods
In this study, 481 patients with locally advanced rectal cancer who underwent preoperative CRT followed by surgical resection between 2004 and 2013 at a single institution were evaluated retrospectively. Pathological good response (p-GR) was defined as ypT ≤ 1, and pathological minimal or no response (p-MR) as ypT ≥ 2. The patients were randomly classified according to two groups, a testing (n=193) and a validation (n=288) group. Endoscopic criteria were determined from endoscopic findings and ypT in the testing group and used in classifying patients in the validation group as achieving or not achieving p-GR.
Results
Based on findings in the testing group, the endoscopic criteria for p-GR included scarring, telangiectasia, and erythema, whereas criteria for p-MR included nodules, ulcers, strictures, and remnant tumors. In the validation group, the kappa statistic was 0.965 (p < 0.001), and the sensitivity, specificity, positive predictive value, and negative predictive value were 0.362, 0.963, 0.654, and 0.885, respectively.
Conclusion
The endoscopic criteria presented are easily applicable for evaluation of ypT after preoperative CRT for rectal cancer. These criteria may be used for selection of patients for local excision of down-staged rectal tumors, because patients with p-MR could be easily ruled out.

Citations

Citations to this article as recorded by

Is Early, Postinduction Restaging of Rectal Cancer Undergoing Total Neoadjuvant Therapy Associated With Ultimate Treatment Response?
William C. Chapman, Emre Gorgun, Sumeyye Yilmaz, David R. Rosen, Michael A. Valente, Joshua Sommovilla, Arielle E. Kanters, Andrei S. Purysko, Alok A. Khorana, Smitha S. Krishnamurthi, Sudha R. Amarnath, Hermann Kessler, Scott R. Steele, David Liska
Diseases of the Colon & Rectum.2025; 68(2): 190. CrossRef
Effects of clinical information on the treatment decisions for good responders to neoadjuvant chemoradiotherapy among rectal cancer patients
Eon Bin Kim, In Ja Park, Hwa Jung Kim, Jong Keon Jang, Seong Ho Park, Young Il Kim, Min Hyun Kim, Jong Lyul Lee, Chan Wook Kim, Yong Sik Yoon, Seok-Byung Lim, Chang Sik Yu
Annals of Coloproctology.2025; 41(5): 473. CrossRef
Endoscopic assessment of rectal cancer response after neoadjuvant chemoradiotherapy: A narrative literature review
Fotios Seretis, Antonia Panagaki, Paraskevas Gkolfakis, Georgios Tziatzios, Konstantina Paraskeva
World Journal of Clinical Oncology.2025;[Epub] CrossRef
The value of multimodality MR in T staging evaluation after neoadjuvant therapy for rectal cancer
Bin Liu, Chuan Sun, Xinyu Zhao, Lingyu Liu, Shuang Liu, Haichuan Ma
Technology and Health Care.2024; 32(2): 615. CrossRef
Feasibility of endoscopic techniques in assessing the radicality of chemoradiotherapy in patients with rectal cancer
A. A. Salimova, M. V. Makarova, M. Yu. Kurdanova, Yu. P. Kuvshinov, I. A. Karasev, T. S. Davydkina
Surgery and Oncology.2024; 14(2): 48. CrossRef
Clinical predictors of pathological good response in locally advanced rectal cancer
Kongfeng Shao, Rong Zheng, Anchuan Li, Xiaobo Li, Benhua Xu
Radiation Oncology.2021;[Epub] CrossRef
A prospective clinical study assessing the presence of exfoliated cancer cells and rectal washout including tumors in patients who receive neoadjuvant chemoradiotherapy for rectal cancer
Kazutake Okada, Sotaro Sadahiro, Yutaro Kamei, Lin Fung Chan, Takashi Ogimi, Hiroshi Miyakita, Gota Saito, Akira Tanaka, Toshiyuki Suzuki
Surgery Today.2020; 50(4): 352. CrossRef
Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: A Multicenter Comparative Cross‐Sectional Study with Rectal Preservation as Supported by Surgeon
Kwang‐Seop Song, Sung Chan Park, Dae Kyung Sohn, Jae Hwan Oh, Min Jung Kim, Ji Won Park, Seung‐Bum Ryoo, Seung‐Yong Jeong, Kyu Joo Park, Heung‐Kwon Oh, Duck‐Woo Kim, Sung‐Bum Kang
World Journal of Surgery.2019; 43(12): 3216. CrossRef
Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer
Dae Kyung Sohn, Kyung Su Han, Byung Chang Kim, Chang Won Hong, Hee Jin Chang, Ji Yeon Baek, Min Ju Kim, Sung Chan Park, Jae Hwan Oh, Dae Yong Kim
Surgical Oncology.2017; 26(4): 453. CrossRef
Advances in organ preserving strategies in rectal cancer patients
Rutger CH. Stijns, Mike-Stephen R. Tromp, Niek Hugen, Johannes HW de Wilt
European Journal of Surgical Oncology.2017;[Epub] CrossRef

13,795 View
131 Download
11 Web of Science
10 Crossref

Robotic Versus Laparoscopic Surgery for Rectal Cancer after Preoperative Chemoradiotherapy: Case-Matched Study of Short-Term Outcomes: Yong Sok Kim, Min Jung Kim, Sung Chan Park, Dae Kyung Sohn, Dae Yong Kim, Hee Jin Chang, Byung-Ho Nam, Jae Hwan Oh; Cancer Res Treat. 2016;48(1):225-231. Published online March 11, 2015; DOI: https://doi.org/10.4143/crt.2014.365

Abstract PDF PubReader ePub

Purpose
Robotic surgery is expected to have advantages over laparoscopic surgery; however, there are limited data regarding the feasibility of robotic surgery for rectal cancer after preoperative chemoradiotherapy (CRT). Therefore, we evaluated the short-term outcomes of robotic surgery for rectal cancer. Materials and Methods Thirty-three patients with cT3N0-2 rectal cancer after preoperative CRT who underwent robotic low anterior resection (R-LAR) between March 2010 and January 2012 were matched with 66 patients undergoing laparoscopic low anterior resection (L-LAR). Perioperative clinical outcomes and pathological data were compared between the two groups.
Results
Patient characteristics did not differ significantly different between groups. The mean operation time was 441 minutes (R-LAR) versus 277 minutes (L-LAR; p < 0.001). The open conversion rate was 6.1% in the R-LAR group and 0% in the L-LAR group (p=0.11). There were no significant differences in the time to flatus passage, length of hospital stay, and postoperative morbidity. In pathological review, the mean number of harvested lymph nodes was 22.3 in R-LAR and 21.6 in L-LAR (p=0.82). Involvement of circumferential resection margin was positive in 16.1% and 6.7%, respectively (p=0.42). Total mesorectal excision (TME) quality was complete in 97.0% in R-LAR and 91.0% in L-LAR (p=0.41). Conclusion In our study, short-term outcomes of robotic surgery for rectal cancer after CRT were similar to those of laparoscopic surgery in respect to bowel function recovery, morbidity, and TME quality. Well-designed clinical trials are needed to evaluate the functional results and longterm outcomes of robotic surgery for rectal cancer.

Citations

Citations to this article as recorded by

Comparison of efficacy and safety between robotic-assisted versus laparoscopic surgery for locally advanced mid-low rectal cancer following neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
Xin-Mao Zhu, Xiao Bai, Hai-Qi Wang, Dong-Qiu Dai
International Journal of Surgery.2025; 111(1): 1154. CrossRef
Robotic Rectal Cancer Surgery: Perioperative and Long-Term Oncological Outcomes of a Single-Center Analysis Compared with Laparoscopic and Open Approach
Shachar Laks, Michael Goldenshluger, Alexander Lebedeyev, Yasmin Anderson, Ofir Gruper, Lior Segev
Cancers.2025; 17(5): 859. CrossRef
Robotic-assisted versus laparoscopic surgery for colorectal cancer in high-risk patients: a systematic review and meta-analysis
S. Gahunia, J. Wyatt, S. G. Powell, S. Mahdi, S. Ahmed, K. Altaf
Techniques in Coloproctology.2025;[Epub] CrossRef
Robotic versus laparoscopic total mesorectal excision for mid–low rectal cancer after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis of oncological, perioperative, and survival-related outcomes
Chen Liu, Yupeng Wu, Huan Liu, Danfeng Zhao, Shukai Wang
Journal of Robotic Surgery.2025;[Epub] CrossRef
The role of robotic-assisted surgery in the management of rectal cancer: a systematic review and meta-analysis
Chenxiong Zhang, Hao Tan, Han Xu, Jiaming Ding
International Journal of Surgery.2024; 110(10): 6282. CrossRef
Robotic-Assisted versus Laparoscopic Surgery for Rectal Cancer: An Analysis of Clinical and Financial Outcomes from a Tertiary Referral Center
Jasper Max Gebhardt, Neno Werner, Andrea Stroux, Frank Förster, Ioannis Pozios, Claudia Seifarth, Christian Schineis, Benjamin Weixler, Katharina Beyer, Johannes Christian Lauscher
Journal of Clinical Medicine.2024; 13(6): 1795. CrossRef
Association of Surgical Approaches and Outcomes in Total Mesorectal Excision and Margin Status for Rectal Cancer
Muhammad Bilal Mirza, Adriana C. Gamboa, Rebecca Irlmeier, Benjamin Hopkins, Scott E. Regenbogen, Katherine A. Hrebinko, Jennifer Holder-Murray, Jason T. Wiseman, Aslam Ejaz, Paul E. Wise, Fei Ye, Kamran Idrees, Alexander T. Hawkins, Glen C. Balch, Aimal
Journal of Surgical Research.2024; 300: 494. CrossRef
Rapidez y Precisión en la Comunicación en Tiempo Real entre el Laboratorio Clínico y el Médico durante la Cirugía Robótica
Alfredo Ibarra-Sánchez, Claudia Soto-Félix, Leticia Cano-Barraza, Delia Barraza-Sámano
Estudios y Perspectivas Revista Científica y Académica .2024; 4(4): 1463. CrossRef
Surgical outcomes of robotic, laparoscopic, and open low anterior resection after preoperative chemoradiotherapy for patients with advanced lower rectal cancer
Sukchol Lim, Yuzo Nagai, Hiroaki Nozawa, Kazushige Kawai, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Yuichiro Yokoyama, Tsuyoshi Ozawa, Shinya Abe, Hiroyuki Anzai, Hirofumi Sonoda, Soichiro Ishihara
Surgery Today.2023; 53(1): 109. CrossRef
Operative and oncological outcomes after robotic rectal resection compared with laparoscopy: a systematic review and meta‐analysis
Julie Flynn, Jose T. Larach, Joseph C. H. Kong, Jessica Rahme, Peadar S. Waters, Satish K. Warrier, Alexander Heriot
ANZ Journal of Surgery.2023; 93(3): 510. CrossRef
Comparison of Operative Time Between Robotic and Laparoscopic Low Anterior Resection for Rectal Cancer:A Systematic Review and Meta-Analysis
Zhen Chen, Hua Yu, Huaping Wu, Pingxi Wang, Fanwei Zeng
Surgical Innovation.2023; 30(3): 390. CrossRef
Robotic Rectal Resection for Rectal Cancer in Elderly Patients: A Systematic Review and Meta-Analysis
Rossella Reddavid, Silvia Sofia, Lucia Puca, Jacopo Moro, Simona Ceraolo, Rosa Jimenez-Rodriguez, Maurizio Degiuli
Journal of Clinical Medicine.2023; 12(16): 5331. CrossRef
Short-term and long-term efficacy in robot-assisted treatment for mid and low rectal cancer: a systematic review and meta-analysis
Huiming Wu, Renkai Guo, Huiyu Li
International Journal of Colorectal Disease.2023;[Epub] CrossRef
Robotic versus laparoscopic surgery for rectal cancer after neoadjuvant chemoradiotherapy: A propensity-score matching analysis
Tzu-Chun Chen, Jin-Tung Liang
Journal of the Formosan Medical Association.2022; 121(8): 1532. CrossRef
Short‐term outcomes of robotic‐assisted surgery following neoadjuvant chemotherapy for lower rectal cancer
Hajime Morohashi, Yoshiyuki Sakamoto, Takuya Miura, Daichi Ichinohe, Shunsuke Kubota, Keisuke Yamazaki, Aika Ichisawa, Yuto Mitsuhashi, Taiichi Wakiya, Kenichi Hakamada
Asian Journal of Endoscopic Surgery.2022; 15(3): 577. CrossRef
Robotic versus Laparoscopic Low Anterior Resection for Rectal Cancer
Aba Khaled M. Farid Uddin
World Journal of Colorectal Surgery.2022; 11(3): 47. CrossRef
Oncological outcomes of robotic-assisted total mesorectal excision after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer
Po-Jung Chen, Wei-Chih Su, Tsung-Kun Chang, Yen-Cheng Chen, Ching-Chun Li, Tzu-Chieh Yin, Hsiang-Lin Tsai, Cheng-Jen Ma, Ching-Wen Huang, Jaw-Yuan Wang
Asian Journal of Surgery.2021; 44(7): 957. CrossRef
Difference in surgical outcomes of rectal cancer by study design: meta-analyses of randomized clinical trials, case-matched studies, and cohort studies
N Hoshino, T Sakamoto, K Hida, Y Takahashi, H Okada, K Obama, T Nakayama
BJS Open.2021;[Epub] CrossRef
Postoperative complications observed with robotic versus laparoscopic surgery for the treatment of rectal cancer
Chengkui Liu, Xiaoqing Li, Qingfeng Wang
Medicine.2021; 100(36): e27158. CrossRef
Robotic and robotic-assisted vs laparoscopic rectal cancer surgery: A meta-analysis of short-term and long-term results
Guojun Tong, Guiyang Zhang, Zhaozheng Zheng
Asian Journal of Surgery.2021;[Epub] CrossRef
Robotic-Assisted vs. Standard Laparoscopic Surgery for Rectal Cancer Resection: A Systematic Review and Meta-Analysis of 19,731 Patients
Kamil Safiejko, Radoslaw Tarkowski, Maciej Koselak, Marcin Juchimiuk, Aleksander Tarasik, Michal Pruc, Jacek Smereka, Lukasz Szarpak
Cancers.2021; 14(1): 180. CrossRef
Robotic versus Laparoscopic Colorectal Surgeries
Anil Heroor, Aysha Khan, Kashish Jain, Akshay Patil, Hitesh Rajendra Singhavi
Indian Journal of Colo-Rectal Surgery.2021; 4(1): 12. CrossRef
Feasibility of robot-assisted surgery in elderly patients with rectal cancer
Wei-Chih Su, Ching-Wen Huang, Cheng-Jen Ma, Po-Jung Chen, Hsiang-Lin Tsai, Tsung-Kun Chang, Yen-Cheng Chen, Ching-Chun Li, Yung-Sung Yeh, Jaw-Yuan Wang
Journal of Minimal Access Surgery.2021; 17(2): 165. CrossRef
Robotic surgery for colorectal disease: review of current port placement and future perspectives
Jong Lyul Lee, Hassan A. Alsaleem, Jin Cheon Kim
Annals of Surgical Treatment and Research.2020; 98(1): 31. CrossRef
Comparison of clinical efficacy between robotic-laparoscopic excision and traditional laparoscopy for rectal cancer
Zhen Chen, Zhuo Li Zhu, Pingxi Wang, Fanwei Zeng
Medicine.2020; 99(27): e20704. CrossRef
Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal Cancer
Tzu-Chieh Yin, Wei-Chih Su, Po-Jung Chen, Tsung-Kun Chang, Yen-Cheng Chen, Ching-Chun Li, Yi-Chien Hsieh, Hsiang-Lin Tsai, Ching-Wen Huang, Jaw-Yuan Wang
Frontiers in Oncology.2020;[Epub] CrossRef
Robotic Total Mesorectal Excision for Rectal Cancer: Current Evidences and Future Perspectives
Je-Ho Jang, Chang-Nam Kim
Annals of Coloproctology.2020; 36(5): 293. CrossRef
Systematic review analysis of robotic and transanal approaches in TME surgery- A systematic review of the current literature in regard to challenges in rectal cancer surgery
Julia K. Grass, Daniel R. Perez, Jakob R. Izbicki, Matthias Reeh
European Journal of Surgical Oncology.2019; 45(4): 498. CrossRef
Robotic Versus Conventional Laparoscopic Surgery for Colorectal Cancer: A Systematic Review and Meta‐Analysis with Trial Sequential Analysis
Ka Ting Ng, Azlan Kok Vui Tsia, Vanessa Yu Ling Chong
World Journal of Surgery.2019; 43(4): 1146. CrossRef
Robotic versus conventional laparoscopic surgery for rectal cancer: systematic review and meta-analysis
Xi-Yu Sun, Lai Xu, Jun-Yang Lu, Guan-Nan Zhang
Minimally Invasive Therapy & Allied Technologies.2019; 28(3): 135. CrossRef
Systemic review and network meta‐analysis comparing minimal surgical techniques for rectal cancer: quality of total mesorectum excision, pathological, surgical, and oncological outcomes
Emanuele Rausa, Federica Bianco, Michael E. Kelly, Alberto Aiolfi, Fausto Petrelli, Gianluca Bonitta, Giovanni Sgroi
Journal of Surgical Oncology.2019; 119(7): 987. CrossRef
TME for rectal cancer: consecutive 70 patients treated with laparoscopic and robotic technique—cumulative experience in a single centre
J. L. Mégevand, E. Lillo, M. Amboldi, L. Lenisa, A. Ambrosi, A. Rusconi
Updates in Surgery.2019; 71(2): 331. CrossRef
Completeness of total mesorectum excision of laparoscopic versus robotic surgery: a review with a meta-analysis
Marco Milone, Michele Manigrasso, Nunzio Velotti, Stefania Torino, Antonietta Vozza, Giovanni Sarnelli, Giovanni Aprea, Francesco Maione, Nicola Gennarelli, Mario Musella, Giovanni Domenico De Palma
International Journal of Colorectal Disease.2019; 34(6): 983. CrossRef
Immediate results of robotic-assisted operations in colorectal surgery
Yu. M. Stojko, A. V. Maksimenkov, A. L. Levchuk, D. A. Kolozyan
Endoskopicheskaya khirurgiya.2019; 25(2): 5. CrossRef
Short-Term Outcomes of Robotic versus Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Cohort Study
Wen-Han Liu, Pei-Jing Yan, Dong-Ping Hu, Peng-Hui Jin, Yao-Chun Lv, Rong Liu, Xiong-Fei Yang, Ke-Hu Yang, Tian-Kang Guo
The American Surgeon™.2019; 85(3): 294. CrossRef
Operative time and length of stay is similar between robotic assisted and laparoscopic colon and rectal resections
Heather R. Nolan, Betsy E. Smith, Michael D. Honaker
Journal of Robotic Surgery.2018; 12(4): 659. CrossRef
Does robotic rectal cancer surgery improve the results of experienced laparoscopic surgeons? An observational single institution study comparing 168 robotic assisted with 184 laparoscopic rectal resections
Rogier M. P. H. Crolla, Paul G. Mulder, George P. van der Schelling
Surgical Endoscopy.2018; 32(11): 4562. CrossRef
Robotic total meso-rectal excision for rectal cancer: A systematic review following the publication of the ROLARR trial
Katie Jones, Mohamed G Qassem, Parv Sains, Mirza K Baig, Muhammad S Sajid
World Journal of Gastrointestinal Oncology.2018; 10(11): 449. CrossRef
Recent surgical advances in colorectal cancer excision: toward optimal outcomes
Cihangir Akyol, Mehmet Ayhan Kuzu
Colorectal Cancer.2017; 5(4): 147. CrossRef
The safety and effectiveness of robot-assisted versus laparoscopic TME in patients with rectal cancer
Xiaofei Li, Tao Wang, Liang Yao, Lidong Hu, Penghui Jin, Tiankang Guo, Kehu Yang
Medicine.2017; 96(29): e7585. CrossRef
Robotic-assisted total mesorectal excision with the single-docking technique for patients with rectal cancer
Ching-Wen Huang, Hsiang-Lin Tsai, Yung-Sung Yeh, Wei-Chih Su, Ming-Yii Huang, Chun-Ming Huang, Yu-Tang Chang, Jaw-Yuan Wang
BMC Surgery.2017;[Epub] CrossRef
Robotic Surgery for Rectal Cancer: An Update in 2015
Jung Myun Kwak, Seon Hahn Kim
Cancer Research and Treatment.2016; 48(2): 427. CrossRef
La chirurgie robotique dans le cancer du rectum
J. Coget, P. E. Colombo, A. Mourregot, D. Traoré, P. Rouanet
Oncologie.2016; 18(5): 305. CrossRef
Robot-assisted versus laparoscopic-assisted surgery for colorectal cancer: a meta-analysis
Xuan Zhang, ZhengQiang Wei, MengJun Bie, XuDong Peng, Cheng Chen
Surgical Endoscopy.2016; 30(12): 5601. CrossRef
Robotics in Colorectal Surgery
Allison Weaver, Scott Steele
F1000Research.2016; 5: 2373. CrossRef

14,956 View
139 Download
44 Web of Science
45 Crossref

First
Prev
Page of 1
Next
Last

Search